Cardiorenal protection of sodium-glucose cotransporter 2 inhibitors beyond diabetes: news from the European Society of Cardiology Congress 2020

Giulia Ferrannini

Open source

DOI
10.1093/ehjcvp/pvaa114
Published
2020-10-21
Container
European Heart Journal - Cardiovascular Pharmacotherapy
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ehjcvp/pvaa114,
  title = {Cardiorenal protection of sodium-glucose cotransporter 2 inhibitors beyond diabetes: news from the European Society of Cardiology Congress 2020},
  author = {Giulia Ferrannini},
  year = {2020},
  journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
  doi = {10.1093/ehjcvp/pvaa114},
  url = {https://doi.org/10.1093/ehjcvp/pvaa114}
}

RIS

TY  - JOUR
TI  - Cardiorenal protection of sodium-glucose cotransporter 2 inhibitors beyond diabetes: news from the European Society of Cardiology Congress 2020
AU  - Giulia Ferrannini
PY  - 2020
JO  - European Heart Journal - Cardiovascular Pharmacotherapy
DO  - 10.1093/ehjcvp/pvaa114
UR  - https://doi.org/10.1093/ehjcvp/pvaa114
ER  - 

APA

Ferrannini, G. (2020). Cardiorenal protection of sodium-glucose cotransporter 2 inhibitors beyond diabetes: news from the European Society of Cardiology Congress 2020. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvaa114

Source records